Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
146.7 DKK | +1.75% | -0.10% | -17.05% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.05% | 1.61B | |
+25.27% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.26% | 233B | |
+5.44% | 201B | |
-10.22% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic's Vaccine Enters European Medicines Agency's Priority Medicines Scheme